POAI - Predictive Oncology Inc Growth-Adjusted Payback Ratio

Predictive Oncology is developing a bioinformatics IT ecosystem for precision cancer therapy selection. The innovator leverages AI and a tumor database to accelerate drug discovery. The current PEG ratio on the GURU.Markets chart illustrates the asset's dynamics, where the 0.00 mark characterizes this parameter. The business structure relies on contracts with various pharma clients, which minimizes the risks associated with laboratory ownership.

The metric is calculated by dividing the P/E ratio by the net income growth rate, allowing for an assessment of the cost of each unit of future growth. A value below one signals a fundamental undervaluation of the asset relative to its expansion. For Predictive Oncology (POAI), which integrates AI into oncotherapy, this indicator reflects the efficiency of capitalizing on its technological advantage. Analyzing the PEG ratio's fair value dynamics helps identify entry points into a growing business.